venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value ($000): $658,029 (100.0% shares, 0.0% debt)

Holdings (8)

ALXO ALX ONCOLOGY HLDGS INC 55.6%

Value ($000) $366,075 Shares 9,699,925 Est. Cost $39.31 Unrealized 0.0%

HRMY HARMONY BIOSCIENCES HLDGS IN 18.1%

Value ($000) $118,807 Shares 3,504,624 Est. Cost $36.46 Unrealized 0.0%

— AKERO THERAPEUTICS INC 11.4%

Value ($000) $75,260 Shares 2,444,311 Est. Cost $19.15 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 6.4%

Value ($000) $42,281 Shares 3,673,374 Est. Cost $11.51 Unrealized —

— METACRINE INC 4.7%

Value ($000) $31,234 Shares 3,059,123 Est. Cost $10.21 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 2.3%

Value ($000) $15,133 Shares 501,584 Est. Cost $15.34 Unrealized +94.7%

— PRECISION BIOSCIENCES INC 1.2%

Value ($000) $7,997 Shares 1,298,191 Est. Cost $17.95 Unrealized —

— VERONA PHARMA PLC 0.2%

Value ($000) $1,242 Shares 199,075 Est. Cost $9.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$366,075	55.6%	$39.31	0.0%	COM	00166B105
HRMY	HARMONY BIOSCIENCES HLDGS IN	3,504,624	$118,807	18.1%	$36.46	0.0%	COM	413197104
—	AKERO THERAPEUTICS INC	2,444,311	$75,260	11.4%	$19.15	—	COM	00973Y108
—	CHECKMATE PHARMACEUTICALS IN	3,673,374	$42,281	6.4%	$11.51	—	COM	162818108
—	METACRINE INC	3,059,123	$31,234	4.7%	$10.21	—	COM	59101E103
APLS	APELLIS PHARMACEUTICALS INC	501,584	$15,133	2.3%	$15.34	+94.7%	COM	03753U106
—	PRECISION BIOSCIENCES INC	1,298,191	$7,997	1.2%	$17.95	—	COM	74019P108
—	VERONA PHARMA PLC	199,075	$1,242	0.2%	$9.65	—	SPONSORED ADS	925050106